Cocksfoot Grass Allergy: Dactylis glomerata and Its Pollen Allergens

Cocksfoot and orchard grass are the same plant species — Dactylis glomerata. 'Cocksfoot' is the common name used in British English, referring to the shape of the flower head that resembles a rooster's foot. 'Orchard grass' is the American English name, reflecting its common use as a forage grass in orchards and pastures. The botanical species is identical, and the allergens (Dac g 1 through Dac g 5) are the same regardless of the common name used. Both names refer to the same grass species that is a major source of allergenic pollen in temperate climates worldwide.

Cocksfoot grass allergy is a specific type of grass pollen allergy, but because the allergens of cocksfoot (Dac g 1, Dac g 5) cross-react extensively with those of other Pooideae grasses (timothy, ryegrass, Kentucky bluegrass), a patient sensitized to cocksfoot is almost always sensitized to multiple grass species. Clinically, 'grass pollen allergy' is treated as a single entity because immunotherapy with a single grass extract (such as timothy) effectively desensitizes patients to the entire grass group. Skin prick testing typically uses a grass pollen panel rather than individual species, and the management approach is the same regardless of which specific grass species is the primary sensitizer.

Anaphylaxis from cocksfoot grass pollen inhalation is extremely rare. The primary presentation of grass pollen allergy is rhinoconjunctivitis (sneezing, runny nose, itchy eyes) and, in some patients, asthma symptoms (coughing, wheezing, chest tightness). Pollen-mediated anaphylaxis is extraordinarily rare for any wind-pollinated plant, including grasses. However, patients with grass pollen allergy who also have profilin sensitization (Dac g 4) may theoretically experience mild systemic reactions after consuming raw plant foods that cross-react with profilin, though these reactions are typically mild and self-limited. Any patient who experiences throat swelling, hives, or breathing difficulty after plant exposure should seek emergency care immediately.

Yes, skin prick testing for cocksfoot grass allergy is available, but it is typically done using a grass pollen panel that includes multiple grass species rather than cocksfoot alone. Commercial skin prick test extracts for individual grass species are available, but because of the extensive cross-reactivity within the Pooideae subfamily, most allergists use a mixed grass panel that includes timothy, ryegrass, Kentucky bluegrass, and other grasses. A positive result to the grass panel confirms sensitization to cocksfoot and other grass species. Specific IgE blood testing (ImmunoCAP) for grass pollen extracts is also available and provides quantitative results.

Yes, cocksfoot grass pollen can cause oral allergy syndrome (OAS) in patients sensitized to the profilin allergen Dac g 4. Profilin is a pan-allergen found in virtually all plant pollens and plant foods. Patients with profilin sensitization may experience tingling, itching, or mild swelling of the lips, mouth, and throat after eating raw fruits and vegetables such as melons, bananas, celery, tomatoes, and stone fruits. These symptoms are typically heat-labile — cooking destroys profilin, so cooked versions of the same foods are usually tolerated. The group 1 and group 5 allergens (Dac g 1, Dac g 5) are not associated with food cross-reactivity.

The highest-risk individuals are those living in temperate climates where cocksfoot is abundant — the Pacific Northwest, northern US states, and Europe. A family history of atopy (allergic rhinitis, asthma, eczema) significantly increases the risk, as does a personal history of other pollen allergies (tree, weed). Outdoor occupations such as farming, landscaping, and gardening, as well as outdoor athletic activities, increase exposure to grass pollen and may elevate the risk of sensitization. Children and young adults are most commonly affected, though new-onset grass pollen allergy can develop at any age.

Cocksfoot grass allergy is not treated differently from other grass pollen allergies because the allergens cross-react so extensively. The pharmacotherapy approach — antihistamines, intranasal corticosteroids, eye drops — is identical. Immunotherapy for grass pollen allergy uses standardized extracts (typically timothy or mixed grass) that cover cocksfoot and all other Pooideae grasses. There is no need for a cocksfoot-specific immunotherapy product because the group 1 and group 5 allergens are structurally homologous across species. The treatment approach is the same regardless of which specific grass species is the primary sensitizer.

Yes, new-onset grass pollen allergy can develop at any age, including adulthood. The mechanism is the same regardless of age: repeated exposure to grass pollen in a genetically susceptible individual can eventually drive IgE sensitization and symptomatic rhinoconjunctivitis. Adults who relocate to a region with high grass pollen exposure (such as the Pacific Northwest) and experience their first late-spring respiratory symptoms after the move may be developing new grass pollen sensitization driven by regional exposure they did not have previously. This clinical presentation — 'I never had allergies before I moved to Oregon' — should prompt evaluation with a grass pollen panel and is entirely consistent with adult-onset sensitization.

No, there is no established link between cocksfoot grass pollen allergy and reactions to grass-fed beef. The allergens in grass pollen (Dac g 1, Dac g 5) are proteins that are not present in meat after cooking. The digestive process breaks down any pollen proteins that might be present in the animal's digestive tract, and the meat itself does not contain grass pollen allergens. Patients with grass pollen allergy can safely consume grass-fed beef, lamb, or dairy products without concern for allergic reactions. This is a common misconception that has no basis in clinical evidence.

The best treatment depends on the severity of your symptoms and your personal preferences. For mild symptoms, second-generation antihistamines (Zyrtec, Claritin, Allegra) taken daily during the grass pollen season are often sufficient. For moderate symptoms, intranasal corticosteroids (Flonase, Nasonex) are the first-line treatment and are more effective than antihistamines alone for nasal congestion. For severe symptoms or patients who want to reduce their reliance on daily medication, allergen immunotherapy (SCIT or SLIT) is the only disease-modifying treatment and offers the most durable long-term benefit. Many patients find that a combination of pre-season nasal steroids, as-needed antihistamines, and immunotherapy provides the best symptom control.